Koenig Serena P, Riviere Cynthia, Leger Paul, Joseph Patrice, Severe Patrice, Parker Kea, Collins Sean, Lee Erin, Pape Jean W, Fitzgerald Daniel W
Division of Global Health Equity, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA.
Clin Infect Dis. 2009 Mar 15;48(6):829-31. doi: 10.1086/597098.
We analyzed mortality among 201 patients with AIDS and tuberculosis in Haiti. Patients who received a diagnosis of tuberculosis during the first 3 months after the initiation of antiretroviral therapy were 3.25 times more likely to die than were other patients with AIDS and tuberculosis. Failure to recognize active tuberculosis at initiation of antiretroviral therapy leads to increased mortality.
我们分析了海地201例艾滋病合并结核病患者的死亡率。在开始抗逆转录病毒治疗后的前3个月内被诊断出患有结核病的患者死亡可能性是其他艾滋病合并结核病患者的3.25倍。在开始抗逆转录病毒治疗时未能识别出活动性结核病会导致死亡率上升。